About
Contact
Subscribe
e-Edition

Make Home Page

Dashboard
Logout

- My Account
- Dashboard
- Profile
- Saved items
- Logout

Facebook
Twitter

- Site search

Home
News
Sports
- Local Sports
- National Sports
Business
Opinion
A & E
Life
Features & Magazines
- WOMEN
- 2026 Readers' Choice Awards
Classifieds
Weather
Obituaries
2026 Readers' Choice Winners

Recent Quotes

View Full List

My Watchlist

Create Watchlist

Indicators

Dow Jones Industrial Average

Markets:

Overview

News

Currencies

International

Treasuries

Axonex AI Group Limited - Class A Ordinary Shares (NQ:AXNX)

0.8250 +0.0650 (+8.55%)

Delayed Quote Updated: 11:23 AM EDT, Oct 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Axonex AI Group Limited - Class A Ordinary Shares

< Previous 1 2 3 4 5 6 7 Next >

FDA Approves Axonics' Recharge-Free Sacral Neuromodulation System ↗

March 08, 2022

The FDA has approved Axonics Inc's (NASDAQ: AXNX) recharge-free sacral neuromodulation (SNM) implantable neurostimulator (INS). The Axonics F15 recharge-free...

Via Benzinga

A Peek Into The Markets: US Stock Futures Gain Following Monday's Sell-Off ↗

March 08, 2022

Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones tumbled around 800 points in the previous session. Investors are awaiting earnings...

Via Benzinga

5 Stocks To Watch - Tuesday, Mar. 8 ↗

March 08, 2022

Some of the stocks that may grab investor focus today.

Via Talk Markets

5 Stocks To Watch For March 8, 2022 ↗

March 08, 2022

Some of the stocks that may grab investor focus today are: Wall Street expects Dick's Sporting Goods, Inc. (NYSE: DKS) to report quarterly earnings at $3.43 per share on...

Via Benzinga

Analyst Ratings For Axonics ↗

February 25, 2022

Axonics (NASDAQ:AXNX) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 1 3...

Via Benzinga

Axonics: Q4 Earnings Insights ↗

February 24, 2022

Axonics (NASDAQ:AXNX) reported its Q4 earnings results on Thursday, February 24, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Axonics...

Via Benzinga

What 4 Analyst Ratings Have To Say About Axonics ↗

January 07, 2022

Axonics (NASDAQ:AXNX) has observed the following analyst ratings within the...

Via Benzinga

Axonics® Reports Fourth Quarter and Fiscal Year 2021 Financial Results

February 24, 2022

From Axonics, Inc.

Via Business Wire

The Daily Biotech Pulse: Orphazyme Plunges On Regulatory Setback In Europe, Pulmonx Earnings Disappoint, Amicus Declines To Spin Off Genetic Medicine Company ↗

February 24, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Adagio Appoints COO David Hering As Interim CEO Adagio Therapeutics, Inc., (...

Via Benzinga

Axonics® to Report Fourth Quarter and Fiscal Year 2021 Financial Results on February 24

February 03, 2022

From Axonics, Inc.

Via Business Wire

The Week Ahead In Biotech (Feb. 20-26): Reata Awaits FDA Decision, Bausch Health, Moderna Lead Earnings News Flow ↗

February 20, 2022

Biotech stock extended lower for a second straight week as risk aversion continued to pressure stocks amid geopolitical tensions and macroeconomic worries. On the regulatory front...

Via Benzinga

Axonics® to Participate in SVB Leerink Virtual Healthcare Conference

February 01, 2022

From Axonics, Inc.

Via Business Wire

New Study Finds More Than 60% of Adult Women in the U.S. Experience Urinary Incontinence

January 25, 2022

From Axonics, Inc.

Via Business Wire

Axonics® Reports Preliminary Fourth Quarter and Fiscal Year 2021 Revenue

January 06, 2022

From Axonics, Inc.

Via Business Wire

Axonics® CEO Raymond W. Cohen Receives Lifetime Entrepreneurial Achievement Award by the Southern California Biomedical Council

November 30, 2021

From Axonics, Inc.

Via Business Wire

Axonics® Ranked the Fastest-Growing Company in North America on the 2021 Deloitte Technology Fast 500™

November 17, 2021

From Axonics, Inc.

Via Business Wire

Axonics® to Participate in Piper Sandler Virtual Healthcare Conference

November 08, 2021

From Axonics, Inc.

Via Business Wire

Axonics Modulation Technologies Inc (AXNX) Q3 2021 Earnings Call Transcript ↗

November 05, 2021

AXNX earnings call for the period ending September 30, 2021.

Via The Motley Fool

Topics Earnings

The Daily Biotech Pulse: NRx's Zyesami Face Regulatory Rejection, Puma Slumps On Q3 Miss, Pfizer Has Good Tidings On Oral Antiviral COVID-19 Pill ↗

November 05, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus NRx's COVID-19 Drug Fails to Get Authorization From FDA Due To...

Via Benzinga

Axonics® Reports Third Quarter 2021 Financial Results

November 04, 2021

From Axonics, Inc.

Via Business Wire

The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO ↗

November 04, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck's Oral Antiviral COVID-19 Pill Authorized In UK Merck &...

Via Benzinga

The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline ↗

October 31, 2021

Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...

Via Benzinga

Axonics® Ranked the Fastest Growing Publicly Traded Company in Orange County

October 26, 2021

From Axonics, Inc.

Via Business Wire

Axonics® to Report Third Quarter 2021 Financial Results on November 4

October 07, 2021

From Axonics, Inc.

Via Business Wire

US Patent Office Rejects Three More Axonics' Challenge To Medtronic Patents ↗

September 23, 2021

The Patent Trial and Appeal Board (PTAB) of the U.S. Patent and Trademark Office has affirmed three Medtronic plc (NYSE: MDT) patents related to its InterStim...

Via Benzinga

Topics Intellectual Property

Axonics® Provides Additional Update on Inter Partes Review Proceedings

September 22, 2021

From Axonics, Inc.

Via Business Wire

The Daily Biotech Pulse: NRx Rises On COVID-19 Drug Collaboration, Amgen's Lung Cancer Drug Conditionally Approved In Canada, Coherus Data Readout ↗

September 14, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 13) Abbott Laboratories (NYSE...

Via Benzinga

Axonics® Announces Partial Decision on Inter Partes Review Proceedings

September 13, 2021

From Axonics, Inc.

Via Business Wire

The Daily Biotech Pulse: Apellis Sinks On Data, Endo Shines On Opioid Litigation Settlement, T2 Biosystems Soars On Mutant Detection Ability of COVID Test ↗

September 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod ↗

September 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Sections

News
Sports
Opinion
Photo Galleries
Videos
Local Events
Classifieds
Obituaries

Services

About
Contact
Personnel
Advertise
Subscription Services
Promote Your Event
Dealer Locations
Email Alerts
Submission Forms

Contact Information

chroniclejournal.com
75 S. Cumberland Street
Thunder Bay, ON P7B 1A3
Phone: 807 343 6200
Email: circulation@chroniclejournal.com

Facebook
Twitter

Browser Compatibility

Your browser is out of date and potentially vulnerable to security risks.
We recommend switching to one of the following browsers:

Microsoft Edge Google Chrome Firefox

Axonex AI Group Limited - Class A Ordinary Shares (NQ:AXNX)

All News about Axonex AI Group Limited - Class A Ordinary Shares

Sections

Services

Contact Information

Follow Us